The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Irritable Bowel Syndrome (IBS)-Global Market Insights and Sales Trends 2025
Synopsis
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
The global Irritable Bowel Syndrome (IBS) market size is expected to reach US$ 12740 million by 2029, growing at a CAGR of 15.0% from 2023 to 2029. The market is mainly driven by the significant applications of Irritable Bowel Syndrome (IBS) in various end use industries. The expanding demands from the Women and Men, are propelling Irritable Bowel Syndrome (IBS) market. IBS-D Drug, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the IBS-C Drug segment is estimated at % CAGR for the next seven-year period.
North America is the largest region of Irritable Bowel Syndrome (IBS), with a market share about 75%. Allergan, Valeant Pharmaceuticals, Takeda, Sucampo Pharmaceuticals and McNeil Consumer Healthcare are the top 5 manufacturers of industry, and they had about 80% combined market share.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Irritable Bowel Syndrome (IBS), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Irritable Bowel Syndrome (IBS) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Irritable Bowel Syndrome (IBS) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Irritable Bowel Syndrome (IBS) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Irritable Bowel Syndrome (IBS) covered in this report include Bausch Health, Allergan, Takeda, Sucampo Pharmaceuticals (Mallinckrodt), Sebela Pharmaceuticals Inc and Astellas Pharmaceuticals, etc.
The global Irritable Bowel Syndrome (IBS) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bausch Health
Allergan
Takeda
Sucampo Pharmaceuticals (Mallinckrodt)
Sebela Pharmaceuticals Inc
Astellas Pharmaceuticals
Global Irritable Bowel Syndrome (IBS) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Irritable Bowel Syndrome (IBS) market, Segment by Type:
IBS-D Drug
IBS-C Drug
Others
Global Irritable Bowel Syndrome (IBS) market, by Application
Women
Men
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Irritable Bowel Syndrome (IBS) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
The global Irritable Bowel Syndrome (IBS) market size is expected to reach US$ 12740 million by 2029, growing at a CAGR of 15.0% from 2023 to 2029. The market is mainly driven by the significant applications of Irritable Bowel Syndrome (IBS) in various end use industries. The expanding demands from the Women and Men, are propelling Irritable Bowel Syndrome (IBS) market. IBS-D Drug, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the IBS-C Drug segment is estimated at % CAGR for the next seven-year period.
North America is the largest region of Irritable Bowel Syndrome (IBS), with a market share about 75%. Allergan, Valeant Pharmaceuticals, Takeda, Sucampo Pharmaceuticals and McNeil Consumer Healthcare are the top 5 manufacturers of industry, and they had about 80% combined market share.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Irritable Bowel Syndrome (IBS), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Irritable Bowel Syndrome (IBS) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Irritable Bowel Syndrome (IBS) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Irritable Bowel Syndrome (IBS) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Irritable Bowel Syndrome (IBS) covered in this report include Bausch Health, Allergan, Takeda, Sucampo Pharmaceuticals (Mallinckrodt), Sebela Pharmaceuticals Inc and Astellas Pharmaceuticals, etc.
The global Irritable Bowel Syndrome (IBS) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bausch Health
Allergan
Takeda
Sucampo Pharmaceuticals (Mallinckrodt)
Sebela Pharmaceuticals Inc
Astellas Pharmaceuticals
Global Irritable Bowel Syndrome (IBS) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Irritable Bowel Syndrome (IBS) market, Segment by Type:
IBS-D Drug
IBS-C Drug
Others
Global Irritable Bowel Syndrome (IBS) market, by Application
Women
Men
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Irritable Bowel Syndrome (IBS) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Irritable Bowel Syndrome (IBS)
1.1 Irritable Bowel Syndrome (IBS) Market Overview
1.1.1 Irritable Bowel Syndrome (IBS) Product Scope
1.1.2 Irritable Bowel Syndrome (IBS) Market Status and Outlook
1.2 Global Irritable Bowel Syndrome (IBS) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Irritable Bowel Syndrome (IBS) Market Size by Region (2018-2029)
1.4 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Region (2018-2023)
1.5 Global Irritable Bowel Syndrome (IBS) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Irritable Bowel Syndrome (IBS) Market Size (2018-2029)
1.6.1 North America Irritable Bowel Syndrome (IBS) Market Size (2018-2029)
1.6.2 Europe Irritable Bowel Syndrome (IBS) Market Size (2018-2029)
1.6.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size (2018-2029)
1.6.4 Latin America Irritable Bowel Syndrome (IBS) Market Size (2018-2029)
1.6.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size (2018-2029)
2 Irritable Bowel Syndrome (IBS) Market by Type
2.1 Introduction
2.1.1 IBS-D Drug
2.1.2 IBS-C Drug
2.1.3 Others
2.2 Global Irritable Bowel Syndrome (IBS) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Type (2018-2023)
2.2.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Irritable Bowel Syndrome (IBS) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Irritable Bowel Syndrome (IBS) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Irritable Bowel Syndrome (IBS) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Breakdown by Type (2018-2029)
3 Irritable Bowel Syndrome (IBS) Market Overview by Application
3.1 Introduction
3.1.1 Women
3.1.2 Men
3.2 Global Irritable Bowel Syndrome (IBS) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Application (2018-2023)
3.2.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Irritable Bowel Syndrome (IBS) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Irritable Bowel Syndrome (IBS) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Irritable Bowel Syndrome (IBS) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Breakdown by Application (2018-2029)
4 Irritable Bowel Syndrome (IBS) Competition Analysis by Players
4.1 Global Irritable Bowel Syndrome (IBS) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome (IBS) as of 2022)
4.3 Date of Key Players Enter into Irritable Bowel Syndrome (IBS) Market
4.4 Global Top Players Irritable Bowel Syndrome (IBS) Headquarters and Area Served
4.5 Key Players Irritable Bowel Syndrome (IBS) Product Solution and Service
4.6 Competitive Status
4.6.1 Irritable Bowel Syndrome (IBS) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bausch Health
5.1.1 Bausch Health Profile
5.1.2 Bausch Health Main Business
5.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Products, Services and Solutions
5.1.4 Bausch Health Irritable Bowel Syndrome (IBS) Revenue (US$ Million) & (2018-2023)
5.1.5 Bausch Health Recent Developments
5.2 Allergan
5.2.1 Allergan Profile
5.2.2 Allergan Main Business
5.2.3 Allergan Irritable Bowel Syndrome (IBS) Products, Services and Solutions
5.2.4 Allergan Irritable Bowel Syndrome (IBS) Revenue (US$ Million) & (2018-2023)
5.2.5 Allergan Recent Developments
5.3 Takeda
5.3.1 Takeda Profile
5.3.2 Takeda Main Business
5.3.3 Takeda Irritable Bowel Syndrome (IBS) Products, Services and Solutions
5.3.4 Takeda Irritable Bowel Syndrome (IBS) Revenue (US$ Million) & (2018-2023)
5.3.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Developments
5.4 Sucampo Pharmaceuticals (Mallinckrodt)
5.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Profile
5.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Main Business
5.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Products, Services and Solutions
5.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue (US$ Million) & (2018-2023)
5.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Developments
5.5 Sebela Pharmaceuticals Inc
5.5.1 Sebela Pharmaceuticals Inc Profile
5.5.2 Sebela Pharmaceuticals Inc Main Business
5.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Products, Services and Solutions
5.5.4 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue (US$ Million) & (2018-2023)
5.5.5 Sebela Pharmaceuticals Inc Recent Developments
5.6 Astellas Pharmaceuticals
5.6.1 Astellas Pharmaceuticals Profile
5.6.2 Astellas Pharmaceuticals Main Business
5.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Products, Services and Solutions
5.6.4 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue (US$ Million) & (2018-2023)
5.6.5 Astellas Pharmaceuticals Recent Developments
6 North America
6.1 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Irritable Bowel Syndrome (IBS) Market Dynamics
11.1 Irritable Bowel Syndrome (IBS) Industry Trends
11.2 Irritable Bowel Syndrome (IBS) Market Drivers
11.3 Irritable Bowel Syndrome (IBS) Market Challenges
11.4 Irritable Bowel Syndrome (IBS) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
